Handelsbanken Fonder AB
Position in KNSA — Kiniksa Pharmaceuticals International, plc
CIK 1398318
STOCKHOLM, V7
Position in KNSA
as of Jun 30, 2026
· filed Jul 10, 2026
Position Value
$1,342,950
New position
Shares Held
21,000
first reported quarter
Ownership
0.014%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#2
of 11 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Handelsbanken Fonder AB holds $87,470,140 across 16 Drug Manufacturers - Specialty & Generic names. KNSA ranks #11 (1.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
205,871 | $34,697,498 | |
| 2 | ZTS |
Zoetis Inc.
|
228,467 | $16,417,638 | |
| 3 | VTRS |
Viatris Inc
|
522,705 | $8,300,555 | |
| 4 | UTHR |
UNITED THERAPEUTICS Corp
|
13,120 | $7,108,809 | |
| 5 | ELAN |
Elanco Animal Health Inc
|
165,300 | $4,068,033 | |
| 6 | ALKS |
Alkermes plc.
|
55,000 | $2,881,725 | |
| 7 | LNTH |
Lantheus Holdings, Inc.
|
23,600 | $2,618,184 | |
| 8 | HIMS |
Hims & Hers Health, Inc.
|
60,000 | $2,080,200 |
All Filings in KNSA
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,342,950 | 21,000 | Shares | Sole | 2026-07-10 | |
| No filing history on record for this holder in this stock. | ||||||